Furthermore, resveratrol has been shown to suppress HK-II expression and glycolysis in non-small cell lung cancer (NSCLC), with the Akt signaling pathway proposed as a key molecular mechanism underlying its anti-tumor effects [91,92]. This evidence concerns the gene AKT1 and neoplasm.